Powered by

-Syndax to Participate in the BTIG Biotechnology Conference

Aug 06, 2019 - ENP Newswire
Event Announcements

WALTHAM - Syndax Pharmaceuticals, Inc. ('Syndax,' the 'Company' or 'we') (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Briggs W. Morrison, M.D., Chief Executive Officer of Syndax, will participate in a panel discussion on targeted oncology therapies at the BTIG Biotechnology Conference on Monday, August 12, 2019 at 4:00 p.m. ET at the St. Regis New York.

About Syndax Pharmaceuticals, Inc.

Syndax P...